Advertisement

Topics

Immune Design Corp. Company Profile

10:42 EST 21st November 2017 | BioPortfolio

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches to enable the body’s immune system to fight disease. The company’s technologies are engineered to activate the immune system’s natural ability to create and/or expand antigen-specific cytotoxic T cells, while enhancing other immune effectors, to fight cancer and other chronic diseases. Immune Design’s three ongoing immuno-oncology clinical programs are the product of its two synergistic discovery platforms, ZVex™ and GLAAS™. Immune Design has offices in Seattle and South San Francisco. For more information, visit www.immunedesign.com.


News Articles [778 Associated News Articles listed on BioPortfolio]

Company Spotlight: Immune Design

Shares of Immune Design (IMDZ) are up an impressive 98% year-to-date, way ahead of the iShares NASDAQ Biotechnology Index's gain of 26% during the same period.

Follow-on funding brings in $80M for Immune Design

A follow-on funding raised $80 million for Immune Design, which intends to launch a late-stage study of CMB305 for synovial s -More- 

Public offering nets $75mm for Immune Design

Immune Design Corp. (immunotherapies for cancer, infectious diseases, and allergies) netted $75mm through a public sale of 19.5mm common shares at $4.10. Money will go towards an upcoming Phase III st...

Immune Design Announces Positive FDA Feedback on Phase 3 Clinical Trial Design for CMB305 in Synovial Sarcoma Patients

CMB305 Monotherapy vs. Placebo in the Maintenance SettingPFS Analysis for Potential Full Approval as Early as 24 Months After Study StartConference Call and Webcast Tomorrow at 5:30am PT/8:30am ET ...

Immune Design Corporation Release: New Randomized Data From CMB305 + Checkpoint Inhibitor Study Demonstrate Greater Clinical Benefit And Immune Response

  Life Sciences Jobs   ...

FDA gives positive opinion on Phase III study of Immune's synovial sarcoma drug

The FDA has given positive feedback on a late-stage study of Immune Design's CMB305, being evaluated as a treatment for patie -More- 

Study identifies new metabolic target in quest to control immune response

(University of Vermont) A surprising discovery that immune cells possess an internal warehouse of glycogen used to activate immune responses could help to increase immune activity in vaccines or suppr...

Immune Design Announces New CMB305 + Checkpoint Inhibitor Topline Data from an Upcoming ...

Interim data analysis shows greater clinical benefit and immune response with CMB305+atezolizumab than with atezolizumab alone SEATTLE and SOUTH SAN FRANCISCO, Calif., Aug. 30, 2017 (GLOBE NEWS...

PubMed Articles [2138 Associated PubMed Articles listed on BioPortfolio]

Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.

To guide the design of immunotherapy strategies for patients with early stage lung tumors, we developed a multiscale immune profiling strategy to map the immune landscape of early lung adenocarcinoma ...

The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation.

The aim of this study was to assess the impact of chemoradiation on the immune microenvironment to influence and optimally design future neoadjuvant clinical trials.

Prospect for immune checkpoint blockade: dynamic and comprehensive monitorings pave the way.

Immune checkpoint blockade, which releases the brake of the immune system to enhance anticancer immune response, stands out in the cancer immunotherapy field due to their remarkable and long-lasting e...

Antigenic Variation and Immune Escape in the MTBC.

Microbes that infect other organisms encounter host immune responses, and must overcome or evade innate and adaptive immune responses to successfully establish infection. Highly successful microbial p...

Clinical Trial Design for Immune-Based Therapy of Hepatitis B Virus.

The treatment paradigm in hepatitis B virus is on the cusp of major development, with a multitude of novel agents undergoing testing for clinical efficacy. Such new immune therapies are urgently requi...

Clinical Trials [3451 Associated Clinical Trials listed on BioPortfolio]

Immune Response to Cytomegalovirus

This study will evaluate immune responses against cytomegalovirus (CMV). About 80 percent of adults have been exposed to this virus. CMV typically remains dormant (inactive) in the body, c...

Effect of Fasting and Refeeding on T-cell Fate

Background: Researchers want to better understand the body s immune response to calorie restriction. To do this, they are asking healthy volunteers to fast for 24 hours. Researchers will ...

Does Implant Design Improve Postoperative Flexion?

This study will evaluate whether design features of one implant design allows more knee bend than the other. Patients will have 1 design in the left knee and 1 design in their right knee....

Participation in a Research Registry for Immune Disorders

Background: - People with primary immune deficiency diseases (PIDD) have weak immune systems. This makes it hard for their bodies to fight infection. The Immune Deficiency Foundation has ...

Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood

The objectives of the study are to determine the impact of interferon-free treatment for the hepatitis C virus (HCV) on peripheral blood immune cell phenotype and soluble immune-related pr...

Companies [1344 Associated Companies listed on BioPortfolio]

Immune Design Corp.

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches to enable the body’s immune system to fight disease. The company’s t...

World of Health Biotech Co.Ltd

Anti HBV Specific Active Immunotherapy (Anti HBV Therapeutic Vaccine) using recombinant hepatitis B vaccine (standard HBV vaccine) as an immunogenic specific antigen and several cytokines as an immune...

Immune-Onc Therapeutics, Inc.

Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a newly established biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatmen...

ATLANTIS DRUG CORP

Nil

NORLOFF COMPUTER CORP

Nil

More Information about "Immune Design Corp." on BioPortfolio

We have published hundreds of Immune Design Corp. news stories on BioPortfolio along with dozens of Immune Design Corp. Clinical Trials and PubMed Articles about Immune Design Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immune Design Corp. Companies in our database. You can also find out about relevant Immune Design Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record